Kathleen Kӧck

SHP656, a polysialylated recombinant factor VIII (PSA‐rFVIII): First‐in‐human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia A

P. Collins, A. Tiede, M. Wolfsegger, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.